Fig. 5. PLS-DA score plot of tumor tissue samples after three weeks
treatment of PP242 at a dose of 60
mg.kg-1.day-1. (A) Metabolomics
(ES⁺; R² = 0.89, Q² = 0.60), (B) metabolomics (ES⁻; R² = 0.94, Q² =
0.52), (C) Lipidomics (ES⁺; R² = 0.99, Q² = 0.87), and Lipidomics (ES⁻;
R² = 0.82, Q² = 0.04).